Innovative biotechnology company
focused on the discovery and the development of biopharmaceuticals to provide innovative therapies in hepatology and oncology disordersMission & Strategy
Founded in 2006
by two hepato-gastro-enterologists, with the idea of bringing new therapeutic perspective for the treatment of liver diseasesHistory & Funding
Strong collaborative research
with its historical partner Inserm-Paris XI unit 785.Collaborative research
ALF-5755 for the treatment of acute liver failure and severe acute hepatitisLearn more +
News & Press
- 2013/11/04 Alfact Innovation presents the results of the phase II trial AASLD liver meeting, Washington, late break poster...
- 2013/11/04 Alfact Innovation announces positive clinical trial results for treatment of AIH- and HBV- related acute-on-chronic liver diseases Paris, November 4 2013 – Alfact Innovation, a young innovative...